<ul><li>Total floor area: 12,350 m²</li><li>Land area: 37,416 m²</li><li>Production: 2,500 m² </li><li>Packaging: 600 m² </li><li>Analytics: 1,200 m² </li><li>FTE: 137 </li><li>Shifts: 24/5</li></ul>

<ul><li>Production of solids<ul><li>Tablets</li><li>Hardcapsules</li><li>Effervescent tablets</li><li>Pellets </li><li>Powder-/pellet-/tablett-filled capsules</li></ul></li><li>OEB 1-3, incl. Narcotics</li><li>Quality services</li></ul>

<ul><li>Technology transfer</li><li>Analytical services</li><li>Integrated project management</li><li>Lifecycle management</li><li>Drug regulatory affaires services</li><li>Pharmacovigilance operations</li></ul>

<ul><li>Tablets (blister)</li><li>Tablets (bottles)</li><li>Tubes (effervescents)</li><li>Integrated serialization &amp; aggregation</li></ul>

<ul><li>Manufacturing licenses<ul><li>EU GMP </li><li>Narcotics</li></ul></li><li>Non EU-GMP certifications<ul><li>US FDA </li><li>ANVISA</li><li>Russian MoH</li></ul></li></ul>

<ul><li>Rx</li><li>OTC</li><li>Food supplements</li></ul>

Technologies

Bulk Equipment 
<ul><li>2 granulation machines (fluid bed dryer and high speed mixer)</li><li>4 pelleting machines </li><li>3 capsules filling machines</li><li>4 tabletting machines</li><li>1 container blender (200 l, 800 l, 1600 l and 2000 l)</li></ul>
Coating
<ul><li>2 tablet coaters (250 kg and 450 kg)</li><li>8 coating pans</li></ul>
Packaging
<ul><li>2 blister lines (incl. serialisation)</li><li>1 bottle filling line tablets (incl. serialisation)</li><li>1 tube filling line effervescents</li></ul>
Quality Control
<ul><li>9 HPLC systems</li><li>9 dissolution testers</li><li>1 UV/VIS spectrophotometer</li><li>1 gas chromatograph</li><li>2 titration systems</li><li>2 particle size analyzers</li><li>5 stability chambers</li><li>2 particle dispersions (wet and dry)</li></ul>

Products

<ul><li>Analgetica (opioids, non-steorids)</li><li>Antiarrhythmica, class I</li><li>Antidepressiva (tricyclic)</li><li>Antihyperkinetica</li><li>Antihypertensiva</li><li>Antimykotica</li><li>Antirheumatica</li><li>Antitussiva</li><li>Antivertiginosa</li><li>Beta blocker</li><li>Cytoprotectors</li><li>Expectorants</li><li>Muscle relaxants</li><li>Parasymphatomimetica</li><li>Phosphate binder</li><li>Sympathomimetica</li><li>Thyreostatica</li><li>Vasodilators</li></ul>

Marburg

The Aenova site in Marburg has special expertise in the production and packaging of moisture-sensitive dosage forms and solid dosage forms.

The Aenova site in Marburg has special expertise in the production and packaging of moisture-sensitive dosage forms, solid dosage forms...

Marburg - Aenova Group

employees

certifications & approvals

square meter

Encapsulation Marburg Aenova

Cleanrooms production Marburg Aenova

Granulation Marburg Aenova

Capsule Weighing Marburg Aenova

Tube filling line Marburg Aenova

Quality control Marburg Aenova

Laboratory building Marburg Aenova

Building bulk production Marburg Aenova

Aenova Site Marburg Oral Solids

Facts

Location Marburg, Germany
Competence Center complex conventional solids and narcotics

The Aenova site in Marburg has special expertise in the production and packaging of moisture-sensitive dosage forms and solid dosage forms.
The Aenova site in Marburg can look back on a history of over one hundred years of pharmaceutical production.
The site processes organic solvents (granulation, drying and coating), handles narcotic substances and manufactures complex immediate and sustained release pellets with small and medium API loadings (non pareil seeds).

New Managing Director at Aenova site in Marburg, Germany

01/03/2023 - New Managing Director at Aenova site in Marburg, Germany

Marburg, 01/03/2023

Effective March 01, 2023, Dr. Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma GmbH, a member of the Aenova Group. The experienced general manager leads the site in Marburg with 150 employees and a focus on complex conventional solids and narcotics.
The Aenova Group is a leading international contract manufacturer and developer for the pharmaceutical and healthcare industry with 16 locations and around 4,200 employees worldwide. The Aenova site Marburg stands out within the group as a competence center for complex conventional solids and narcotics. With around 150 employees, the Aenova site in Marburg manufactures delayed-release tablets and capsules as well as moisture-sensitive dosage forms. Dr. Hanno Scheffczik has been appointed as the new Managing Director as of March 01, 2023. He replaces the long-standing managing director Dr. Alfred Veit, who is retiring.Dr. Hanno Scheffczik studied chemistry with a focus on biochemistry and earned his doctorate at the Institute of Virology at Philipps University in Marburg. After holding various development and management positions at well-known, international research-based pharmaceutical companies, he joined Aenova in 2021, initially as Head of Manufacturing Science & Technology. "I am looking forward to my tasks in Marburg and to working with a highly competent and committed team!", says Dr. Scheffczik. The Aenova site in Marburg has a history of over a century in pharmaceutical development and production and is one of the larger local employers. The company has particular expertise in the development and production of complex pellets with controlled release of active ingredients, such as encapsulated mini-tablets and multi-unit pellet systems (MUPS). This is aimed at improving the bioavailability of active pharmaceutical ingredients and is an example of the innovative strength of the Aenova site in Marburg. The site is GMP and FDA certified, among others. "With Dr. Scheffczik we have a long-standing experienced manager and expert who knows the industry and Aenova very well. We wish him every success in his new role," explains Jan Kengelbach, CEO of the Aenova Group.

Auf einen Blick

At a glance

Jan Kengelbach

Dr. Peter Waller

Dr Peter Waller

Tim Bauer

Anne-Sophie Bonte, Ph.D.

Florent Bordet, Ph.D.

Florent Bordet, Ph. D.

Neil Jones

Management

Aufsichtsrat

Supervisory Board

Bad Aibling

Carugate

Cornu

Feldkirchen

Greensboro

Gronau

Killorglin

Kirchberg

Latina

Münster

Regensburg

Sisseln

Starnberg

Tittmoning

Standorte

Manufacturing Sites

Compliance

Nachhaltigkeit

Corporate Sustainability

Werte

Values

Ressourcen

Resources

Unternehmen

Company

Tablets

Hard Capsules

Effervescents, Lozenges, Chewables

High potent solids

Controlled release

Beta Lactam Antibiotics

Solida

Solids

Liquid Vials

Prefilled Syringes

Beta Lactams

Fill & Finish of Biologics

Sterile Technologien

Sterile Technologies

Non-Sterile Liquids

Ointments and creams

Suppositories

Semisolida & nicht sterile Flüssigkeiten

Semi-solids & Non sterile Liquids

Soft Gelatin Capsules

VegaGels®

Weichgelatine Kapseln

Softgel Capsules

Blister

Vials & Ampoules

Bottles & Tubes, Cans & Jars

Cartons & Boxes

Services

Verpackungs-Services

Packaging Services

Qualität

Quality

Pharmazeutische Fertigung

Pharmaceutical Manufacturing

Semisolids & Liquids

Soft Gel Capsules

Sterile Injectables

Entwicklung von Arzneimitteln

Drug Product Development

Analytische Entwicklung

Analytical Development

Clinical Trial Supply Management

Regulatorische Unterstützung

Regulatory Support

Technologie Transfer

Technology Transfer

Entwicklung & Technologie

Development & Technology Services

Haustiere

Companion Animals

Nutztiere

Farm Animals

Tiergesundheit

Animal Health

Investoren

Investor Relations

Arbeiten bei Aenova

Working at Aenova

Karrierestufen

Career Levels

Ihre Bewerbung bei Aenova

Your application at Aenova

Job Portal

Karriere

Career

News

Events

News & Events

Presse Portal

Press Portal

Marburg

The Production Plant

Manufacturing Services

Development Services

Packaging Services

Certifications & Approvals

Product Types

Address

News